CDER Clinical Review Template

First Page		Document Content
Haemophilia Recombinant proteins Medical statistics Pharmaceutical industry Factor VIII Fresh frozen plasma Moroctocog alfa Von Willebrand disease Coagulation Blood Coagulation system Anatomy		CDER Clinical Review Template Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 715,06 KB Share Document on Facebook

	Microsoft Word - Report Coagulation Factors June 2013 DocID: M8ar - View Document
	Summary Basis for Regulatory Action Date: [removed]From: Irwin M. Feuerstein, M.D., M.S., M.B.A., Chair of the BLA BLA/STN#: [removed]Applicant Name: Pfizer Incorporated / Wyeth Biopharma Division of Wyeth Pharmaceu DocID: I02q - View Document
	RECOMBINATE [Antihemophilic Factor (Recombinant)] Lyophilized Powder for Reconstitution for injection Reconstitute with 10 mL of Sterile Water for Injection using Baxject II DESCRIPTION DocID: HU3U - View Document
	RECOMBINATE [Antihemophilic Factor (Recombinant)] Lyophilized Powder for Reconstitution for injection Reconstitute with 5 mL of Sterile Water for Injection using Baxject II DESCRIPTION DocID: HTdJ - View Document
	RECOMBINATE Antihemophilic Factor (Recombinant) Lyophilized Powder for Reconstitution for injection Reconstitute with 5 mL of Sterile Water for Injection using double-ended needles DocID: HNXB - View Document